(Q43142304)

14 November 2017

title

(18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging (English)

1 reference

14 November 2017

2

Elif Hindié

0 references

author name string

Gerard Moulin-Romsee

1

1 reference

14 November 2017

Elif Hindié

2

1 reference

14 November 2017

Xavier Cuenca

3

1 reference

14 November 2017

Pauline Brice

4

1 reference

14 November 2017

Didier Decaudin

5

1 reference

14 November 2017

Myriam Bénamor

6

1 reference

14 November 2017

Josette Brière

7

1 reference

14 November 2017

Marcela Anitei

8

1 reference

14 November 2017

Jean-Emmanuel Filmont

9

1 reference

14 November 2017

David Sibon

10

1 reference

14 November 2017

Eric de Kerviler

11

1 reference

14 November 2017

Jean-Luc Moretti

12

1 reference

14 November 2017

publication date

4 March 2010

1 reference

14 November 2017

number of pages

11

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

14 November 2017

volume

37

1 reference

14 November 2017

issue

6

1 reference

14 November 2017

page(s)

1095-1105

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-009-1377-5

14 November 2017

exact match

0 references

cites work

Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose for initial staging of hodgkin lymphoma: a single center experience in Brazil.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-009-1377-5

The EORTC strategy in the treatment of Hodgkin's lymphoma.

21 January 2018

1 reference

12 December 2020

Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.

1 reference

12 December 2020

Revised response criteria for malignant lymphoma

1 reference

12 December 2020

18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis.

1 reference

12 December 2020

Bilateral Trephine Bone Marrow Biopsies in Lymphoma and Other Neoplastic Diseases

1 reference

12 December 2020

Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake.

1 reference

12 December 2020

Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin's disease.

1 reference

12 December 2020

Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?

1 reference

12 December 2020

Survival after Hodgkin lymphoma: causes of death and excess mortality in patients treated in 8 consecutive trials

1 reference

12 December 2020

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting

1 reference

12 December 2020

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

1 reference

12 December 2020

Positron emission tomography in the staging of patients with Hodgkin's lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi.

1 reference

12 December 2020

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model

1 reference

12 December 2020

Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.

1 reference

12 December 2020

18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow

1 reference

12 December 2020

Bone marrow involvement in Hodgkin's disease: an analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study Group

1 reference

12 December 2020

Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.

1 reference

12 December 2020

Bone marrow biopsy morbidity and mortality: 2002 data

1 reference

12 December 2020

Bone involvement in patients with lymphoma: the role of FDG-PET/CT.

1 reference

12 December 2020

Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy.

1 reference

12 December 2020

Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

1 reference

12 December 2020

State-of-the-art therapeutics: Hodgkin's lymphoma

1 reference

12 December 2020

Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial.

1 reference

12 December 2020

Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study

1 reference

12 December 2020

Utility of positron emission tomography (PET) scanning in managing patients with Hodgkin lymphoma

1 reference

12 December 2020

Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's disease

1 reference

12 December 2020

New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group

1 reference

12 December 2020

Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma.

1 reference

12 December 2020

The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines.

1 reference

12 December 2020

Hodgkin's disease--from pathology specimen to cure

1 reference

12 December 2020

Diagnosis and classification of malignant lymphoma and related entities in the bone marrow trephine biopsy

1 reference

12 December 2020

Managing relapsed and refractory Hodgkin lymphoma

1 reference

12 December 2020

Early, intermediate and advanced Hodgkin's lymphoma: modern treatment strategies

1 reference

12 December 2020

Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease

1 reference

12 December 2020

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

1 reference

12 December 2020

FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.

1 reference

12 December 2020

Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review

1 reference

12 December 2020

The biology of Hodgkin's lymphoma

1 reference

12 December 2020

FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease.

1 reference

12 December 2020

Magnetic resonance imaging for the detection of bone marrow involvement in malignant lymphoma

1 reference

12 December 2020

Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up

1 reference

12 December 2020

Staging Hodgkin's Disease with 18-FDG PET Comparison with CT and Surgery

1 reference

12 December 2020

Detection of lymphoma in bone marrow by whole-body positron emission tomography

1 reference

12 December 2020

Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma

1 reference

12 December 2020

The value of bone marrow examination in the staging of Hodgkin's lymphoma: a review of 955 cases seen in a regional cancer centre

1 reference

12 December 2020

Report of the Committee on Hodgkin's Disease Staging Classification

1 reference

12 December 2020

Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study

1 reference

12 December 2020

Positron emission tomography/computed tomography

1 reference

12 December 2020

10.1007/S00259-009-1377-5

Identifiers

DOI

1 reference

14 November 2017

1 reference